CBG is often referred to as the "mother" of cannabinoids because it is the precursor to all other cannabinoids. Cannabigerol (CBG) is a non-intoxicating cannabinoid found in the cannabis plant. Unlike THC, it doesn't change with heat (decarboxylation) into delta-9-THC.
At harvest, CBG is usually found in smaller quantities in cannabis plants compared to THC and CBD. However, harvesting and processing young plants for extraction can yield higher levels of CBG. Selective breeding and genetic modification of cannabis strains have also led to higher CBG concentrations in some plants.
CBG works by binding to both endocannabinoid receptors, CB1 and CB2, where studies have found it strengthens the function of anandamide. As the mother of all cannabinoids, CBG possesses all cannabinoids effects except delta-9-THC intoxication.
Possible uses include:
For seniors and those impacted by neurodegenerative diseases, CBG supports brain health, making it a promising area for new wellness products aimed at brain health maintenance.
One of the most unexpected benefits of CBG is its role in appetite suppression. This diverges from the well-known "munchies" associated with high-THC cannabis strains, positioning CBG as an intriguing aid in weight management.
CBG can be found in various products, including:
The 2018 Farm Bill states that hemp plants containing less than 0.3% THC are federally legal. CBGA, present in both cannabis and hemp plants, directly correlates to hemp plants’ CBG and CBD potency. Farmers can derive CBG from hemp plants, and numerous hemp farmers now breed and grow CBG-rich strains that don’t require a trip to the dispensary or a medical marijuana card to access.
Because CBG isn’t abundant in most strains, breeders have begun crossbreeding plants to achieve higher levels of the cannabinoid. Farms like Oregon CBD have won multiple awards for their White CBG strain, which contains around 10% CBG and less than 0.3% THC. However, hemp products are not yet required to be tested or taxed.